AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $362,617 | -14.5% | 5,189 | -12.1% | 0.00% | 0.0% |
Q2 2023 | $424,170 | -0.4% | 5,902 | -14.5% | 0.00% | 0.0% |
Q1 2023 | $425,802 | +8.4% | 6,904 | +35.5% | 0.00% | 0.0% |
Q4 2022 | $392,785 | +44.4% | 5,096 | -16.7% | 0.00% | 0.0% |
Q3 2022 | $272,000 | +38.1% | 6,116 | +19.4% | 0.00% | – |
Q2 2022 | $197,000 | -16.9% | 5,121 | -6.1% | 0.00% | – |
Q1 2022 | $237,000 | +9.2% | 5,453 | -4.8% | 0.00% | – |
Q4 2021 | $217,000 | +11.3% | 5,730 | -2.9% | 0.00% | – |
Q3 2021 | $195,000 | -30.1% | 5,901 | +42.3% | 0.00% | -100.0% |
Q2 2021 | $279,000 | +47.6% | 4,147 | +24.6% | 0.00% | – |
Q1 2021 | $189,000 | +33.1% | 3,328 | +90.9% | 0.00% | – |
Q4 2020 | $142,000 | +6.8% | 1,743 | -6.7% | 0.00% | – |
Q3 2020 | $133,000 | -39.3% | 1,869 | -30.0% | 0.00% | -100.0% |
Q2 2020 | $219,000 | -21.8% | 2,669 | -43.9% | 0.00% | 0.0% |
Q1 2020 | $280,000 | – | 4,759 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |